| Trial Identifier: | ALXN1210-PNH-302 |
| Sponsor: | Alexion Pharmaceuticals |
| Start Date: | June 2017 |
| Primary Completion Date: | March 2018 |
| Study Completion Date: | March 2022 |
| Condition: | Heart, Blood & Circulatory - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Dutch (Netherlands) | |
| English (Australia) | |
| English (Canada) Translation | |
| English (United Kingdom) | |
| French (Canada) Translation | |
| French (France) Translation | |
| German (Germany) Translation |
| Country | Location |
|---|---|
| Australia, Australian Capital Territory | Canberra, Australian Capital Territory, Australia, 2605 |
| Australia, New South Wales | Kogarah, New South Wales, Australia, 2217 |
| Australia, New South Wales | Liverpool, New South Wales, Australia, 2170 |
| Australia, Queensland | Woolloongabba, Queensland, Australia, 4102 |
| Australia, Victoria | Parkville, Victoria, Australia, 3050 |
| Canada, Ontario | Toronto, Ontario, Canada, M4N 3M5 |
| Canada, Ontario | Toronto, Ontario, Canada, M5G 2C4 |
| Canada, Quebec | Montréal, Quebec, Canada, H1T 2M4 |
| France | Amiens, France, 80054 |
| France | Marseille, France, 13273 |
| France | Paris, France, 75475 |
| France | Pierre-Bénite, France, 69495 |
| France | Saint-Priest-en-Jarez, France, 42271 |
| France | Strasbourg, France, 67091 |
| Germany, Baden Wuerttemberg | Ulm, Baden Wuerttemberg, Germany, 89081 |
| Germany, Nordrhein Westfalen | Aachen, Nordrhein Westfalen, Germany, 52074 |
| Germany, Nordrhein Westfalen | Essen, Nordrhein Westfalen, Germany, 45147 |
| Italy | Firenze, Italy, 50134 |
| Italy | Milano, Italy, 20122 |
| Italy | Napoli, Italy, 80131 |
| Italy | Torino, Italy, 10126 |
| Italy | Vicenza, Italy, 36100 |
| Japan, Fukushima | Fukushima, Japan, 960-1295 |
| Japan, Ishikawa | Kanazawa-shi, Ishikawa, Japan, 920-8641 |
| Japan, Nagano | Suwa, Nagano, Japan, 392-8510 |
| Japan, Osaka | Suita-shi, Osaka, Japan, 565-0871 |
| Japan, Tokyo | Shinagawa-Ku, Tokyo, Japan, 141-8625 |
| Netherlands | Maastricht, Netherlands, 6229 |
| Netherlands | Nijmegen, Netherlands, 6525 |
| South Korea | Daegu, South Korea, 42415 |
| South Korea | Daejeon, South Korea, 35015 |
| South Korea | Gyeonggi-do, South Korea, 16247 |
| South Korea | Gyeonggi-do, South Korea, 14584 |
| South Korea | Incheon, South Korea, 21565 |
| South Korea | Seoul, South Korea, 06351 |
| South Korea | Seoul, South Korea, 06591 |
| South Korea | Seoul, South Korea, 03722 |
| South Korea | Seoul, South Korea, 03080 |
| Spain | Barcelona, Spain, 08036 |
| Spain | Madrid, Spain, 28040 |
| Spain | Majadahonda, Spain, 28222 |
| United Kingdom | Airdrie, United Kingdom, ML6 9JS |
| United Kingdom | Leeds, United Kingdom, LS9 7TF |
| United Kingdom | London, United Kingdom, SE5 9RS |
| United States, California | Duarte, California, United States, 91010 |
| United States, California | Los Angeles, California, United States, 90033 |
| United States, Maryland | Baltimore, Maryland, United States, 21205 |
| United States, Michigan | Detroit, Michigan, United States, 48202 |
| United States, New York | Bronx, New York, United States, 10467 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company